SPECIAL FOCUS: PRECLINICAL STUDIES IN LARGE ANIMALS RESEARCH ARTICLES A Preclinical Study in Rhesus Macaques for Cystic Fibrosis to Assess Gene Transfer and Transduction by AAV1 and AAV5 with a Dual-Luciferase Reporter System

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments

  2017cited by this paper
• CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes.

  2016cited by this paper
• Parvovirus glycan interactions.

  2014cited by this paper
• A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial.

  2014cited by this paper
• Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene

  2013cited by this paper
• Immune responses to AAV vectors: overcoming barriers to successful gene therapy.

  2013cited by this paper
• Reduced Airway Surface pH Impairs Bacterial Killing in the Porcine Cystic Fibrosis Lung

  2012cited by this paper
• New Technology Offers New Opportunities : Continuous Bronchodilator Therapy During Mechanical Ventilation

  2012cited by this paper
• Distinct Transduction Difference Between Adeno-Associated Virus Type 1 and Type 6 Vectors in Human Polarized Airway Epithelia

  2012cited by this paper
• Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life.

  2011cited by this paper
• Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation

  2011cited by this paper
• Evaluation of the disease liability of CFTR variants.

  2011cited by this paper
• Recommendations for the classification of diseases as CFTR-related disorders.

  2011cited by this paper
• Dual reporter comparative indexing of rAAV pseudotyped vectors in chimpanzee airway.

  2010influential reference
• Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses.

  2009cited by this paper
• Large-Scale Adeno-Associated Viral Vector Production Using a Herpesvirus-Based System Enables Manufacturing for Clinical Studies

  2009cited by this paper
• Expression of a truncated cystic fibrosis transmembrane conductance regulator with an AAV5-pseudotyped vector in primates.

  2007cited by this paper
• Repeated Aerosolized AAV-CFTR for Treatment of Cystic Fibrosis: A Randomized Placebo-Controlled Phase 2B Trial

  2007cited by this paper
• Prevalence of Neutralizing Antibodies Against Adeno-Associated Virus (AAV) Types 2, 5, and 6 in Cystic Fibrosis and Normal Populations: Implications for Gene Therapy Using AAV Vectors

  2006influential reference
• Recent developments in recombinant AAV-mediated gene therapy for lung diseases.

  2005cited by this paper
• Functional Characterization of a Recombinant Adeno- Associated Virus 5-Pseudotyped Cystic Fibrosis Transmembrane Conductance Regulator Vector

  2004cited by this paper
• Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial.

  2004cited by this paper
• Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues

  2004cited by this paper
• Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques.

  2003cited by this paper
• Deposition and expression of aerosolized rAAV vectors in the lungs of Rhesus macaques.

  2002cited by this paper
• A Phase II, Double-Blind, Randomized, Placebo-Controlled Clinical Trial of tgAAVCF Using Maxillary Sinus Delivery in Patients with Cystic Fibrosis with Antrostomies

  2002cited by this paper
• In utero AAV-mediated gene transfer to rabbit pulmonary epithelium.

  2001cited by this paper
• A Phase I Study of Aerosolized Administration of tgAAVCF to Cystic Fibrosis Subjects with Mild Lung Disease

  2001cited by this paper
• Rate limiting steps of AAV transduction and implications for human gene therapy.

  2001cited by this paper
• Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus.

  2000cited by this paper
• Delayed Expression of Adeno-Associated Virus Vector DNA

  1999cited by this paper
• Repeated Delivery of Adeno-Associated Virus Vectors to the Rabbit Airway

  1999cited by this paper
• Safety and Biological Efficacy of an Adeno‐Associated Virus Vector–Cystic Fibrosis Transmembrane Regulator (AAV‐CFTR) in the Cystic Fibrosis Maxillary Sinus

  1999cited by this paper
• A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis.

  1998cited by this paper
• Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus.

  1998cited by this paper
• Polarity Influences the Efficiency of Recombinant Adenoassociated Virus Infection in Differentiated Airway Epithelia

  1998cited by this paper
• Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.

  1996cited by this paper
• In vivo model of adeno-associated virus vector persistence and rescue

  1996cited by this paper
• Gene therapy for cystic fibrosis.

  1995cited by this paper
• Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter.

  1993cited by this paper

• Development and Validation of AAV-Mediated Liver, Liver-VAT, and Liver-Brain SORT and Therapeutic Regulation of FASN in Hepatic De Novo Lipogenesis

  2025cites this paper
• Long-read structural variant discovery and targeted short read genotyping enables population scale characterization of structural variation in rhesus macaques

  2025cites this paper
• Amelioration of airway and GI disease in G551D-CF ferrets by AAV1 and AAV6

  2024cites this paper
• Adeno-associated virus therapies: Pioneering solutions for human genetic diseases.

  2024cites this paper
• Genome Editing for Cystic Fibrosis

  2023cites this paper
• Transduction of Ferret Surface and Basal Cells of Airways, Lung, Liver, and Pancreas via Intratracheal or Intravenous Delivery of Adeno-Associated Virus 1 or 6

  2023cites this paper
• Multiplexing AAV Serotype-Specific Neutralizing Antibodies in Preclinical Animal Models and Humans

  2023cites this paper
• Endobronchial Aerosolized AAV1.SERCA2a Gene Therapy in a Pulmonary Hypertension Pig Model: Addressing the Lung Delivery Bottleneck

  2022cites this paper
• Short-Term Steroid Treatment of Rhesus Macaque Increases Transduction

  2021cites this paper
• Towards Human Translation of Lentiviral Airway Gene Delivery for Cystic Fibrosis: A One-Month CFTR and Reporter Gene Study in Marmosets

  2021cites this paper
• Application of Nanomaterials in the Diagnosis and Treatment of Genetic Disorders

  2020cites this paper
• Transduction of Surface and Basal Cells in Rhesus Macaque Lung Following Repeat Dosing with AAV1CFTR

  2020influential citation
• Intra-tracheal delivery of AAV6 vectors results in sustained transduction in murine lungs without genomic integration

  2020cites this paper
• Improved Aerosol Delivery System for Intubated Animals

  2020influential citation
• Intra-tracheal amikacin spray delivery in healthy mechanically ventilated piglets.

  2019cites this paper
• Development of lentiviral airway gene therapy aerosol delivery techniques for cystic fibrosis

  2019cites this paper
• Aerosol Inhalation-mediated Delivery of an Adeno-associated Virus 5-expressed Antagonistic Interleukin-4 Mutant Ameliorates Experimental Murine Asthma.

  2019cites this paper
• Immunoengineering of the Vascular Endothelium to Silence MHC Expression During Normothermic Ex Vivo Lung Perfusion

  2019cites this paper
• Self‐complementary and tyrosine‐mutant rAAV vectors enhance transduction in cystic fibrosis bronchial epithelial cells

  2018cites this paper
• Gene Therapy for Cystic Fibrosis Lung Disease: Overcoming the Barriers to Translation to the Clinic

  2018cites this paper
• [Establishment of a suitable control reporter plasmid of a dual luciferase reporter gene system for hormone research in silkworm cell lines].

  2018cites this paper
• Viral Vectors in Gene Therapy

  2018cites this paper
• The Gene Therapy Resource Program: A Decade of Dedication to Translational Research by the National Heart, Lung, and Blood Institute

  2017cites this paper